These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32300784)

  • 1. Characteristics of drug resistance in HIV-1 CRF55_01B from ART-experienced patients in Guangdong, China.
    Lan Y; Xin R; Cai W; Deng X; Li L; Li F; Cai X; Tang X; Fan Q; Hu F
    J Antimicrob Chemother; 2020 Jul; 75(7):1925-1931. PubMed ID: 32300784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance and genetic transmission characteristics of HIV-1 CRF59_01B in infected patients in Guangdong Province, China.
    Lan Y; Li F; Li L; Deng X; Li L; Li J; Cai X; Ling X; Hu F
    J Antimicrob Chemother; 2022 Jun; 77(7):1960-1968. PubMed ID: 35484082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural presence of V179E and rising prevalence of E138G in HIV-1 reverse transcriptase in CRF55_01B viruses.
    Liu Y; Li H; Wang X; Han J; Jia L; Li T; Li J; Li L
    Infect Genet Evol; 2020 Jan; 77():104098. PubMed ID: 31678241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Diversity and Drug Resistance of HIV-1 CRF55_01B in Guangdong, China.
    Yu G; Li Y; Huang X; Zhou P; Yan J; Yan X; Fu X; Fang Y; Liu J; Li J; He X; Lin P
    Curr HIV Res; 2020; 18(3):210-218. PubMed ID: 32294040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana.
    Diphoko T; Gaseitsiwe S; Kasvosve I; Moyo S; Okatch H; Musonda R; Wainberg M; Makhema J; Marlink R; Novitsky V; Essex M
    AIDS Res Hum Retroviruses; 2018 Aug; 34(8):667-671. PubMed ID: 29732907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genotype distribution, infection stage and drug resistance mutation profile of human immunodeficiency virus-1 among the infected blood donors from five Chinese blood centers, 2014-2017.
    Liang S; Liu Z; Wang S; Liu J; Shi L; Mao W; Liu C; Wan J; Zhu L; Huang M; Liu Y; Wang J; Ness P; Shan H; Zeng P; He M
    PLoS One; 2020; 15(12):e0243650. PubMed ID: 33347449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution characteristics of drug resistance mutations of HIV CRF01_AE, CRF07_BC and CRF08_BC from patients under ART in Ganzhou, China.
    Xie YN; Zhu FX; Zhong YT; Chen YT; Gao Q; Lai XL; Liu JJ; Huang DD; Zhang YN; Chen X
    J Antimicrob Chemother; 2021 Oct; 76(11):2975-2982. PubMed ID: 34402512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and transmission of pretreatment drug resistance in people living with HIV-1 in Shanghai China, 2017-2021.
    Zhang M; Ma Y; Wang Z; Wang G; Wang Q; Li X; Lin F; Zhang C
    Virulence; 2024 Dec; 15(1):2373105. PubMed ID: 38934465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRF08_BC subtype is more prone to ART failure and new-generation NNRTI-resistance under long-term first-line ART.
    Wu M; Dong Y; Zeng L; Lin Y; Yao L; Zhang Y; Sun W; Sun J; Wang Q; Yuan D; Xiao H
    Int J Antimicrob Agents; 2024 Aug; 64(2):107215. PubMed ID: 38795930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China.
    Wang Z; Zhang M; Zhang R; Liu L; Shen Y; Wang J; Lu H
    BMC Infect Dis; 2019 Apr; 19(1):313. PubMed ID: 30961560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The profile of HIV-1 drug resistance in Shanghai, China: a retrospective study from 2017 to 2021.
    Zhang M; Ma Y; Wang G; Wang Z; Wang Q; Li X; Lin F; Qiu J; Chen D; Shen Y; Zhang C; Lu H
    J Antimicrob Chemother; 2024 Mar; 79(3):526-530. PubMed ID: 38300833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Drug Resistance and Genetic Transmission Networks Among MSM Failing Antiretroviral Therapy in South China 2014-2019.
    Lan Y; Deng X; Li L; Cai W; Li J; Cai X; Li F; Hu F; Lei C; Tang X
    Infect Drug Resist; 2021; 14():2977-2989. PubMed ID: 34377002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of acquired drug resistance mutations in antiretroviral- experiencing subjects from 2012 to 2017 in Hunan Province of central South China.
    Zou X; He J; Zheng J; Malmgren R; Li W; Wei X; Zhang G; Chen X
    Virol J; 2020 Mar; 17(1):38. PubMed ID: 32183889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.
    Hamers RL; Sigaloff KC; Wensing AM; Wallis CL; Kityo C; Siwale M; Mandaliya K; Ive P; Botes ME; Wellington M; Osibogun A; Stevens WS; Rinke de Wit TF; Schuurman R;
    Clin Infect Dis; 2012 Jun; 54(11):1660-9. PubMed ID: 22474222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in HIV-1 Drug Resistance Mutations from a U.S. Reference Laboratory from 2006 to 2017.
    Kagan RM; Dunn KJ; Snell GP; Nettles RE; Kaufman HW
    AIDS Res Hum Retroviruses; 2019 Aug; 35(8):698-709. PubMed ID: 31169022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of doravirine for the treatment of HIV-1-infected persons with transmitted drug resistance.
    Rhee SY; Schapiro JM; Saladini F; Zazzi M; Khoo S; Shafer RW
    AIDS Res Ther; 2023 Feb; 20(1):8. PubMed ID: 36750835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022.
    Wang Z; Jiang H; Pang X; Li J; Liang S; Huang J; Li D; Hou W; Chen N; Lan G
    J Antimicrob Chemother; 2024 Oct; 79(10):2575-2585. PubMed ID: 39045823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virologic status and pattern of drug resistance mutation among ART-experienced HIV-infected patients in Butuo County, China.
    Chen M; Wu M; Zeng L; Zhang Y; Huobu-Mo M; Li J; Li C; Xiao H
    J Glob Antimicrob Resist; 2023 Mar; 32():98-103. PubMed ID: 36708768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance mutations in HIV type 1 isolates from patients failing antiretroviral therapy in Morocco.
    El Annaz H; Recordon-Pinson P; Tagajdid R; Doblali T; Belefquih B; Oumakhir S; Sedrati O; Mrani S; Fleury H
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):944-8. PubMed ID: 21919803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.
    Svärd J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sönnerborg A
    PLoS One; 2017; 12(6):e0178942. PubMed ID: 28582463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.